OBJECTIVE: Despite the established role of MRI in the diagnosis of brain tumours, histopathological assessment remains the clinically used technique, especially for the glioma group. Relative cerebral blood volume (rCBV) is a dynamic susceptibility-weighted contrast-enhanced perfusion MRI parameter that has been shown to correlate to tumour grade, but assessment requires a specialist and is time consuming. We developed analysis software to determine glioma gradings from perfusion rCBV scans in a manner that is quick, easy and does not require a specialist operator. METHODS: MRI perfusion data from 47 patients with different histopathological grades of glioma were analysed with custom-designed software. Semi-automated analysis was performed with a specialist and non-specialist operator separately determining the maximum rCBV value corresponding to the tumour. Automated histogram analysis was performed by calculating the mean, standard deviation, median, mode, skewness and kurtosis of rCBV values. All values were compared with the histopathologically assessed tumour grade. RESULTS: A strong correlation between specialist and non-specialist observer measurements was found. Significantly different values were obtained between tumour grades using both semi-automated and automated techniques, consistent with previous results. The raw (unnormalised) data single-pixel maximum rCBV semi-automated analysis value had the strongest correlation with glioma grade. Standard deviation of the raw data had the strongest correlation of the automated analysis. CONCLUSION: Semi-automated calculation of raw maximum rCBV value was the best indicator of tumour grade and does not require a specialist operator. ADVANCES IN KNOWLEDGE: Both semi-automated and automated MRI perfusion techniques provide viable non-invasive alternatives to biopsy for glioma tumour grading.
OBJECTIVE: Despite the established role of MRI in the diagnosis of brain tumours, histopathological assessment remains the clinically used technique, especially for the glioma group. Relative cerebral blood volume (rCBV) is a dynamic susceptibility-weighted contrast-enhanced perfusion MRI parameter that has been shown to correlate to tumour grade, but assessment requires a specialist and is time consuming. We developed analysis software to determine glioma gradings from perfusion rCBV scans in a manner that is quick, easy and does not require a specialist operator. METHODS: MRI perfusion data from 47 patients with different histopathological grades of glioma were analysed with custom-designed software. Semi-automated analysis was performed with a specialist and non-specialist operator separately determining the maximum rCBV value corresponding to the tumour. Automated histogram analysis was performed by calculating the mean, standard deviation, median, mode, skewness and kurtosis of rCBV values. All values were compared with the histopathologically assessed tumour grade. RESULTS: A strong correlation between specialist and non-specialist observer measurements was found. Significantly different values were obtained between tumour grades using both semi-automated and automated techniques, consistent with previous results. The raw (unnormalised) data single-pixel maximum rCBV semi-automated analysis value had the strongest correlation with glioma grade. Standard deviation of the raw data had the strongest correlation of the automated analysis. CONCLUSION: Semi-automated calculation of raw maximum rCBV value was the best indicator of tumour grade and does not require a specialist operator. ADVANCES IN KNOWLEDGE: Both semi-automated and automated MRI perfusion techniques provide viable non-invasive alternatives to biopsy for glioma tumour grading.
Authors: Soonmee Cha; Tarik Tihan; Forrest Crawford; Nancy J Fischbein; Susan Chang; Andrew Bollen; Sarah J Nelson; Michael Prados; Mitchel S Berger; William P Dillon Journal: AJNR Am J Neuroradiol Date: 2005-02 Impact factor: 3.825
Authors: K M Donahue; H G Krouwer; S D Rand; A P Pathak; C S Marszalkowski; S C Censky; R W Prost Journal: Magn Reson Med Date: 2000-06 Impact factor: 4.668
Authors: G Brasil Caseiras; J S Thornton; T Yousry; C Benton; J Rees; A D Waldman; H R Jäger Journal: AJNR Am J Neuroradiol Date: 2008-04-03 Impact factor: 3.825
Authors: K E Emblem; D Scheie; P Due-Tonnessen; B Nedregaard; T Nome; J K Hald; K Beiske; T R Meling; A Bjornerud Journal: AJNR Am J Neuroradiol Date: 2008-06-26 Impact factor: 3.825
Authors: Nasuda Danchaivijitr; Adam D Waldman; Daniel J Tozer; Christopher E Benton; Gisele Brasil Caseiras; Paul S Tofts; Jeremy H Rees; H Rolf Jäger Journal: Radiology Date: 2008-04 Impact factor: 11.105
Authors: Antoine Verger; Christian P Filss; Philipp Lohmann; Gabriele Stoffels; Michael Sabel; Hans J Wittsack; Elena Rota Kops; Norbert Galldiks; Gereon R Fink; Nadim J Shah; Karl-Josef Langen Journal: Eur J Nucl Med Mol Imaging Date: 2017-08-22 Impact factor: 9.236